To further evaluate our assay concept, we designed a drug library consisting of 58 different small molecules relevant to ovarian cancer treatment covering a five-point concentration range for each drug, referred to here as the OC repurposing library (Fig. 1c, for full description of the OC library see Supplementary Table 2). Here, BGLAP is linked to ovarian carcinoma.